Variable yet frequent expression of h-caldesmon and desmin further supports the myoid lineage, whereas negative staining for markers such as S100, CD34, and CD31 rules out schwannomas, solitary fibrous tumors, and vascular endothelial lesions, respectively. This evidence concerns the gene DES and schwannoma.